By Harmik Sohi, Director – Injectables and Specialty Formulations, Jubilant Pharma
For many drug developers and manufacturing sites, performing the transfer of a product or technology from a small-scale development process (or R&D process) to full-scale commercial manufacturing can prove challenging. Finding the right contract manufacturing organization (CMO) partner to help navigate this scale-up can greatly simplify the process. However, vetting CMOs for their capacity, expertise, and capabilities can pose its own unique challenges.
When it comes to the tech transfer of sterile injectables, vetting manufacturing partners is about more than the availability of the facilities or the equipment itself. Companies should also look for CMO partners that offer end-to-end support necessary to maximize production while guaranteeing safety, quality and efficiency.
Jubilant HollisterStier has a wide range of manufacturing capabilities and experience for both aseptically filled and terminally sterilized products, including small molecules, biologics-protein containing products, liquid and lyophilized products, liposomes, oligonucleotides, cold kits for radiopharmaceuticals, and vaccines. Its facilities, capabilities, and equipment, coupled with the expertise and support services that enable rapid scale-up and transfer, make Jubilant an ideal partner for sterile injectable manufacturing.
In this article, review Jubilant's new investments for continued growth and its capabilities, facilities and equipment.